RBC Capital analyst Chris Dendrinos maintained a Hold rating on Sunnova Energy International (NOVA – Research Report) yesterday and set a price ...
Hosted on MSN19d
Goldman Sachs maintains buy on Ultragenyx, target at $78Goldman Sachs also expressed confidence in the Phase 3 Orbit study of setrusumab for osteogenesis imperfecta. RBC Capital Markets reiterated an Outperform rating, expressing optimism about the ...
Royal Bank of Canada (RBC) also reported a 48% increase in net income for its wealth-management division, reaching $980 ...
Royal Bank of Canada beat estimates on higher results in its capital-markets and wealth-management divisions as both units ...
Chinese authorities are rolling out fresh measures to limit capital flight, including increased scrutiny of overseas ...
Goldman Sachs is poised to benefit from an anticipated resurgence in capital markets activity. Analysts are optimistic about the company's prospects in this core area of its business, with several ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results